Document Fragment View
Fragment Information
Showing contexts for: intermediate component in Fmc Corporation & Ors. vs Gsp Crop Science Private Limited on 14 November, 2022Matching Fragments
S.No Patent No. Expiry Claims
1 IN252356 July 29, HX is used in Bromination step
WO2004011453 A2 2023 for preparing acid intermediate
2022/DHC/004849
2 IN252004 July 29, Condensation step of acid
WO2004011447 A2 2023 intermediate and amide
intermediate in the presence of
optionally substituted pyridine to
obtain benzoxazone intermediate.
3 IN234856 Mar 25, Ester Intermediate process by
WO2004087689 A1 2023 reacting the 3-chlro-2-
pyridylhydrazine with methyl-2-
bromo-4-chloro-4-oxobutanoate
in the preparation of suitable acid
scavenger and solvent.
4 IN 256246 Jun 10, Benzoxazinone Intermediate
WO2004111030 A1 2024 process
5 IN 298645 Dec 06, Condensation step of Acid
WO2006062978 A1 2025 intermediate and amide
intermediate in the presence of
methylsufonychloride to obtain
chlorantraniliprole
6 IN261551 Mar 14, Ester Intermediate process using
WO 2006102025 A 2026 oxidation step (Oxidation step in
the presence of Br2/pyridine)
7 IN273352 Jun 27, Claim 1: A process for the
WO2008010897 A2 2027 preparation of
Chlorantraniliprole using 3,1-
Benzoxazine-2,4(1H)-dione
intermediate.
8 IN 202117023135 Dec 03, Claims: Condensation step of
of FMC 2039 if Acid intermediate and amide
Corporation granted intermediate in the presence of
WO2020117493 A1 methylsufonylchloride using
continuous process to obtain
chlorantraniliprole.
9 IN 202217028579 Nov 22, Claims: A process for the
A of FMC 2040 if preparation of
Corporation granted Chlorantraniliprole intermediate
WO2021/102393A1 (AC/CHP intermediate) using
Catalyst.
10 IN 202117061288 Nov 11, Claims: A process for the
2022/DHC/004849
A of FMC 2040 if preparation Chlorantraniliprole
Corporation WO granted intermediate (BPC-III
2021/096903 A1 intermediate) via oxidation step
and starting material is added in
second time before completing
reaction.
11 IN 202217008145 Aug 19, Claims: A process for the
A of FMC 2040 if preparation Chlorantraniliprole
Corporation granted intermediate (BPC-II
WO2021034904 A1 intermediate) via bromination
step using POBr3/Br2.
12 IN 202117061264 Nov 11, Claims: A process for the
A of FMC 2040 if preparation Chlorantraniliprole
Corporation WO granted intermediate (ADB intermediate)
2021086957 A1 using 3,1-Benzoxazine-2,4 (1H)-
dione intermediate.
13 WO2021142344 A1 National Claims: A process for the
of FMC phase to be preparation of Acid intermediate
Corporation entered by (BPC intermediate) via oxidation
Jun 08, step using inorganic base.
14 WO2021076838 A1 National Claims: A process for the
of FMC phase to be preparation of Acid intermediate
Corporation entered by (BPC intermediate) by reacting
IN202117061286 Jun 18, pyrazole compound with pyridine.
15 IN 202217021500 Oct 16, Claims: A process for the
A of FMC 2040 if preparation of Acid intermediate
Corporation granted (BPC intermediate) using
WO2021076832 A1 carbonyl containing compound.
16 IN 202117061284 Oct 16, Claims: A process for the
A of FMC 2040 if preparation of Acid intermediate
Corporation granted (BPC intermediate) using sulfonyl
WO2021076831 A1 pyrazole intermediate.
17 IN 202117061265 Claims: A process for the
A of FMC preparation of Acid intermediate
Corporation (BPC intermediate) using
WO2021076835 A1 halogenated pyrazole
2022/DHC/004849
intermediate.
18 WO2021076839 A1 Claims: A process for the
of FMC preparation of Acid intermediate
Corporation IN (BPC intermediate) using novel
202117061285 A intermediates (Nitrile compound)
19 WO2022/020540 National Claim 1: A three-component
A1 of FMC phase to be crystal comprising BPC
entered by intermediate, ADB intermediate
Feb 23, and base (3-picoline), which is
2023 used in the preparation of
Chlorantraniliprole.
20 IN 202117023135 May 24, Claim 1: A process for
A of FMC 2041 if preparation of
granted Chlorantraniliprole/Cyantranilipr
ole using sulfonyl chloride.
21 WO2022/020547 National Claim 1: A composition
A1 of FMC phase to be comprising a crystalline organic
entered by pesticide (AC01 or AC02), BPC
Feb 23, intermediate, ADB or ACD
2023 intermediate, amine base and an
aprotic solvent.
Claim 11: A process for the
preparation of AC01 or AC02
using methyl sulfonyl chloride.
22 WO2022/164871 National Claims: A process for the
A1 of FMC phase to be preparation of Acid intermediate
entered by of Chlorantraniliprole using
Aug 29, carbonyl containing compound.
23 IN 202117061288 November Method for synthesizing Ethyl-3-
of FMC 11, 2039, if bromo-1-(3-chloropyridin-2-yl)-
granted 1H-pyrazole-5-carboxylate useful
for preparation of
Chlorantraniliprole and
Cyantraniliprole
24 IN 202117061286 October This disclosure is directed to
of FMC 18, 2039, if novel methods of synthesizing 5-
2022/DHC/004849
granted Bromo-2-(3-chloro-pyridin-2-yl)-
2H-pyrazole-3-carboxylic acid.
Compounds prepared by the
methods disclosed herein are
useful for preparation of certain
anthranilamide compounds that
are of interest as insecticides,
such as, for example, the
insecticides chlorantraniliprole
and cyantraniliprole.
25 IN 202117061285 February This disclosure is directed to
of FMC 27, 2040, if novel methods of synthesizing 5-
granted Bromo-2-(3-chloro-pyridin-2-yl)-
2H-pyrazole-3-carboxylic acid.
Compounds prepared by the
methods disclosed herein are
useful for preparation of certain
anthranilamide compounds that
are of interest as insecticides,
such as, for example, the
insecticides chlorantraniliprole
and cyantraniliprole.
26 IN 202117061284 November This disclosure is directed to
of FMC 06, 2039, if novel methods of synthesizing 5-
granted Bromo-2-(3-chloro-pyridin-2-yl)-
2H-pyrazole-3-carboxylic acid.
Compounds prepared by the
methods disclosed herein are
useful for preparation of certain
anthranilamide compounds that
are of interest as insecticides,
such as, for example, the
insecticides chlorantraniliprole
and cyantraniliprole.
27 IN 202117061264 November This disclosure is directed to
of FMC 01, 2039, if novel methods of synthesizing 2-
granted amino-5-chloro-N, 3-
dimethylbenzamide. Compounds
2022/DHC/004849
prepared by the methods
disclosed herein are useful for
preparation of certain
anthranilamide compounds that
are of interest as insecticides,
such as, for example, the
insecticides chlorantraniliprole
and cyantraniliprole.
28 IN 202217008145 August 22, This disclosure relates to the
of FMC 2039, if preparation of 3-halo-4, 5-
granted dihydro-1H-pyrazoles using a
novel one-step bromination
process. Compounds prepared by
the process disclosed herein are
useful for preparation of certain
anthranilamide compounds that
are of interest as insecticides,
such as, for example, the
insecticides chlorantraniliprole
and cyantraniliprole.
29 IN 202217021500 November This disclosure is directed to
of FMC 11, 2039, if novel methods of synthesizing 5-
granted Bromo-2-(3-chloro-pyridin-2-yl)-
2H-pyrazole-3-carboxylic acid.
Compounds prepared by the
methods disclosed herein are
useful for preparation of certain
anthranilamide compounds that
are of interest as insecticides,
such as, for example, the
insecticides chlorantraniliprole
and cyantraniliprole.
30 IN 202217028579 November This disclosure is directed to
of FMC 22, 2039, if novel methods of synthesizing (3-
granted chloro-2-pyridyl)hydrazine.
Compounds prepared by the
methods disclosed herein are
useful for preparation of certain
2022/DHC/004849
anthranilamide compounds that
are of interest as insecticides,
such as, for example, the
insecticides chlorantraniliprole
and cyantraniliprole.
29. Any party, which intends to launch CTPR post the expiry of the product/process patent, would be forced to examine this complex maze of patents and patent applications, even after the product and the process claimed in IN‟332 has fallen in public domain.
30. Admittedly, the Markush patent and both the product and process patents relating to CTPR have expired in August 2022 and there can be no exclusivity in the same. However, if one goes by the list of granted and pending patents applications, the various components, intermediates and manufacturing processes of CTPR, if granted/validated, would result in the Plaintiffs monopoly and exclusive rights till 2041 i.e., a further period of 19 years.